A groundbreaking clinical trial launched October 16, 2023, will explore the promise of new drug treatments for military personnel and veterans suffering from post-traumatic stress disorder (PTSD). The multi-site trial is spearheaded by the U.S. Army Medical Materiel Development Activity (USAMMDA), part of the U.S. Army Medical Research and Development Command, and supported by a project team that includes representatives from the U.S. Air Force, Army, Navy, and Special Operations Command. (U.S. Army Courtesy Photo/Released)
| Date Taken: | 10.26.2023 |
| Date Posted: | 10.26.2023 16:15 |
| Photo ID: | 8091306 |
| VIRIN: | 231026-A-A4491-1001 |
| Resolution: | 5549x3699 |
| Size: | 4.13 MB |
| Location: | FORT DETRICK, MARYLAND, US |
| Web Views: | 118 |
| Downloads: | 12 |
This work, Study seeks new treatments for post-traumatic stress disorder in veterans, military personnel, must comply with the restrictions shown on https://www.dvidshub.net/about/copyright.
